Overview
Lock Pharma is a distributor of innovative products for central venous access in the fields of renal therapy, hematology, and oncology. They offer products such as Citra-Lock™ syringe ampoules for securing central catheters, Citra-Valve™ needleless connectors for hemodialysis, and Citra-XS™ biocompatible catheters designed for blood flow. Additionally, they provide WoundClot, a sterile, bioabsorbable dressing for managing moderate to severe arterial and venous bleeding.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-01-22. Active
12 1090 1014 0000 0001 2251 5373- 06 1090 1014 0000 0001 2251 5384
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
51 tenders recorded as contractor: 8 national ($253,707) and 43 EU ($16,807,053).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 5, 2026 | Dostawy leków, preparatów do żywienia dojelitowego, surowców farmaceutycznych, kontrastów, płynów infuzyjnych oraz roztworów zabezpieczających cewnik. | –– | Specjalistyczny Szpital Im. E. Szczeklika w Tarnowie | |
| Oct 5, 2026 | „Dostawa wyrobów medycznych w podziale na zadania” | –– | Szpital Wolski Im. Dr Anny Gostyńskiej sp. z o.o. | |
| Oct 5, 2026 | Dostawy materiałów zużywalnych do ciągłych terapii nerkozastępczych na 24 miesiące - znak sprawy: Z/70/PN/26 | –– | Regionalny Szpital Specjalistyczny Im. Dr. Władysława Biegańskiego |
Public sector contracts
Lock Pharma is the contractor in 18 public sector contracts, worth PLN 504.88k in total. They were signed with 15 public buyers.
| Public buyer | Value | |
|---|---|---|
| Zespół Opieki Zdrowotnej w Końskich | PLN 5,400 | |
| Regionalny Szpital Specjalistyczny Im. Dr. Władysława Biegańskiego | PLN 59,900 | |
| Uniwersytecki Szpital Kliniczny w Opolu | PLN 42,240 | |
| Uniwersytecki Szpital Kliniczny w Białymstoku | PLN 5,177 | |
| Specjalistyczny Szpital Im. E. Szczeklika w Tarnowie | PLN 18,000 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board is authorised independently to effectively submit declarations concerning the company’s proprietary and non-proprietary rights and obligations and to sign agreements on behalf of the company. If the value of the rights or liabilities exceeds PLN 100,000 (one hundred thousand złoty), the consent of the partners’ meeting is required. In the case of a multi-member management board, joint action by at least two members of the management board or by a member of the management board and a commercial proxy (joint representation) is required to effectively submit declarations concerning the company’s proprietary and non-proprietary rights and obligations and to sign agreements on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bartosz Stebnicki (51) | 20,102 | $271,501.89 | 99.5149% |
Others | 98 | $1,323.61 | 0.4851% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
ACME Partnerssp. z o.o. | 45,380.88 USD | 80% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | ||
| Genoplast BiotechS.A. | $1,843,484.74 | genoplast.pl | ||
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| Optimed Pro-Office Cirrosp. j. | $1,276,876.90 | cirro.pl | ||
| Surgical Solutionssp. z o.o. | $947,852.75 | surgical-solutions.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | ||
| Model MedicalS.A. | $754,014.76 | modelmedical.pl | ||
| Kunctradesp. z o.o. | $720,968.35 | kunctrade.com | ||
| Support-Pharmasp. z o.o. | $521,132.71 | support-pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-28 | Share capital change (10,000.00 PLN → 1,010,000.00 PLN) | |
| 2018-11-28 | PKD change (Added: 46.62.Z) | |
| 2016-02-19 | Name change ("lock Pharma" → Lock Pharma) | |
| 2016-02-19 | PKD change (Removed: 20.42.Z, 46.51.Z, 52.10) | |
| 2015-12-28 | PKD change (Removed: 18.20.Z, 20.53.Z, 26.51.Z, 26.60.Z, 26.70.Z, 46.18.Z, 46.19.Z, 46.45.Z, 46.52.Z, 46.75.Z, 46.90.Z, 47.19.Z, 47.29.Z, 47.41.Z, 47.99.Z, 58.29.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 70.10.Z, 70.21.Z, 71.20.A, 71.20.B, 72.11.Z, 72.19.Z, 73.20.Z, 74.10.Z, 74.20.Z, 74.30.Z, 74.90.Z, 77.40.Z, 78.30.Z, 85.60.Z, 86.90.E, 96.09.Z) |
FAQ
Last updated: 2026-07-15